SCIENCE IN THE NEWS DAILY
Promising Alzheimer's Drug Approved for Late-Stage Trials
from USA Today
An experimental drug for Alzheimer's disease patients showed promise in Phase II clinical trials and is moving into final-stage trials, Wyeth and Elan, the makers of bapineuzumab, announced Tuesday.
Bapineuzumab is designed to fight beta amyloid, a toxic protein that clumps together in the brains of Alzheimer's patients.
In the early studies, conducted around the USA, 240 people with early- to moderate-stage Alzheimer's disease were either assigned bapineuzumab or a placebo. Researchers reported that non-carriers of a gene considered to be a risk factor for Alzheimer's disease, called ApoE4, showed "clinically meaningful benefits" in a battery of tests used to track the progression of Alzheimer's disease.
Read more ...
Connect With Us:
VIDEO: From Biology to Military History: Patterns in Animal Weaponry
What are the parallels between an ancient war ship and a dung beetle? More than you would think, actually! Douglas J. Emlen, PhD, has a unique perspective on animal weaponry that looks at patterns in military history.
To view all multimedia content, click "Latest Multimedia"!
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.